Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

From heart to blood: LTBP-2 is a promising biomarker for pulmonary arterial hypertension

LTBP-2 expression is increased in the right ventricle and plasma of patients with pulmonary arterial hypertension. Circulating levels of LTBP-2 correlate with right ventricular function and predict long-term survival in two independent cohorts of patients with pulmonary arterial hypertension.

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Fig. 1: LTBP-2 expression in patients with PAH and correlation with prognosis.

References

  1. Lahm, T. et al. Assessment of right ventricular function in the research setting: knowledge gaps and pathways forward. an official american thoracic society research statement. Am. J. Respir. Crit. Care Med. 198, e15–e43 (2018). A Review article that provides the roadmap to further advance the state of knowledge in the field of RV failure.

    Article  Google Scholar 

  2. Prisco, S. Z., Thenappan, T. & Prins, K. W. Treatment targets for right ventricular dysfunction in pulmonary arterial hypertension. JACC Basic Transl. Sci. 5, 1244–1260 (2020). A Review article that presents the mechanisms of right ventricular dysfunction in PAH and highlights potential targets for supporting RV function.

    Article  Google Scholar 

  3. Rhodes, C. J. et al. Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort study. Lancet Resp. Med. 5, 717–726 (2017). A paper that reports a combination of nine circulating proteins identified in an unbiased screen that predicted the survival of patients with PAH.

    CAS  Article  Google Scholar 

  4. Rhodes, C. J. et al. Using the plasma proteome for risk stratifying patients with pulmonary arterial hypertension. Am. J. Respir. Crit. Care. Med. 205, 1102–1111 (2022). A paper that presents the prognostic value of several circulating proteins in PAH that complement natriuretic peptide tests (NT-proBNP) and clinical risk scores.

    CAS  Article  Google Scholar 

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Boucherat, O. et al. Identification of LTBP-2 as a plasma biomarker for right ventricular dysfunction in human pulmonary arterial hypertension. Nat. Cardiovasc. Res. https://doi.org/10.1038/s44161-022-00113-w (2022).

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

From heart to blood: LTBP-2 is a promising biomarker for pulmonary arterial hypertension. Nat Cardiovasc Res 1, 804–805 (2022). https://doi.org/10.1038/s44161-022-00121-w

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s44161-022-00121-w

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing